Los Angeles Business News - Page 22

Page 22 of Los Angeles Business News issued by the Send2Press® Newswire service.



DermHair Clinic Provides New Hope and Applies New Technique for Baldness

LOS ANGELES, Calif. (SEND2PRESS NEWSWIRE) — DermHair Clinic, a division of FineTouch Dermatology, Inc., located in Redondo Beach, Calif., offers a unique hair-restoration procedure called ‘Body Hair Transplantation’ (BHT) where body hair is transplanted to balding areas on the head. Dr. Umar, a board-certified dermatologist and cosmetic surgeon, reports that he routinely performs hair transplantation procedures that combine head and body hair.

Updated: Japanese Study Confirms Safety and Efficacy of Intravenous Rexin-G as Treatment for Diverse Metastatic Cancers

SAN MARINO, Calif. and TOKYO, Japan – Dec. 6, 2006 (SEND2PRESS NEWSWIRE) — Epeius Biotechnologies announced today the first results of an independent study conducted in Japan that further documents the safety and efficacy of intravenous Rexin-G(TM) in a broad spectrum of patients with chemo-resistant metastatic cancer. Although the study began in October, only two months ago, the initial reports are both encouraging and noteworthy.

Japanese Study Confirms Safety and Efficacy of Intravenous Rexin-G(TM) as Treatment for Diverse Metastatic Cancers

SAN MARINO, Calif. and TOKYO, Japan – Dec. 6 (SEND2PRESS NEWSWIRE) — Epeius Biotechnologies announced today the first results of an independent study conducted in Japan that further documents the safety and efficacy of intravenous Rexin-G in a broad spectrum of patients with chemo-resistant metastatic cancer. Although the study began in October, only two months ago, the initial reports are both encouraging and noteworthy. The lead investigator of the Japanese study, Dr. Takaki Imamura, will be presenting his findings and clinical recommendations at a special medical conference to be held in Tokyo, Japan, on December 16, 2006.

Neotrope Announces the Relaunch of Online News and Lifestyle Magazine eNewsChannels

TORRANCE, Calif. – Dec. 1 (SEND2PRESS NEWSWIRE) — Neotrope(R), a 24 year old entertainment, publishing, brand marketing and content company, announced today the formal re-launch of its online news and lifestyle magazine, eNewsChannels(TM). The publication (at www.eNewsChannels.com) features articles on social issues, personal well being, and entertainment. Selected news stories from the offbeat to the fascinating are included. The publication is edited by veteran journalist Christopher Laird Simmons, with a varied list of storied contributors.

Intellikey Labs tests DVD Copy Protection

GLENDALE, Calif. – Nov. 10 (SEND2PRESS NEWSWIRE) — Intellikey Labs, the first and most established content and DVD testing lab, is on the forefront of DVD content copy protection testing. Utilizing its proprietary protocols developed specifically for copy protection testing, Intellikey performs definitive copy protection testing for optical media via its expansive domestic and international DVD player matrices.

Rexin-G(TM), The World’s First Tumor-Targeted Gene Therapy Vector, Stymies Metastatic Cancer

SAN MARINO, Calif. and MANILA, Philippines – Nov. 6 (SEND2PRESS NEWSWIRE) — Epeius Biotechnologies today announced the publication of clinical data from studies conducted at the University of the Philippines, Asian Hospital and Medical Center, Makati Medical Center, Manila, Philippines and Lutheran Medical Center, New York, USA, revealing the safety and single agent efficacy of Rexin-G(TM) for the treatment of a broad spectrum of chemotherapy-resistant cancers.

LeadPolice Announces New Options for Lead Buyers

LONG BEACH, Calif. (SEND2PRESS NEWSWIRE) — LeadPolice.com, the premier resource for Lead Buyers, has announced new membership options for Lead Buyers in the Mortgage, Insurance and Real Estate Industries.

Epeius Biotechnologies Affirms Leadership Role in The Development of Genetic Medicine

SAN MARINO, Calif. – Oct. 11 (SEND2PRESS NEWSWIRE) — Epeius Biotechnologies Corporation today announced that Dr. Frederick Hall, President and CEO of Epeius Biotechnologies, has accepted an invitation to speak at the upcoming Global Pharmaceutical Research & Development Summit held on Oct. 24 at 4:10 p.m. (PT) in Anaheim, Calif. Dr. Hall will present the current status of global development and the broad pharmaceutical indications for the company’s innovative targeting technology platform that has enabled Epeius to develop Rexin-G(TM).

Java Juice Liquid Coffee Extract Makes Splash in Multi-Markets: Coffee On-Demand Goes Green

VENICE, Calif. – Oct. 2 (SEND2PRESS NEWSWIRE) — Early this year master coffee roaster Richard Karno decided to nano-package his organic liquid extract, called Java Juice(R). Since then the product has gone from obscurity to must have mechanism in multi-markets. Java Juice(R) is garnering raves from marketing authorities including trend analyst, Faith Popcorn.

Neotrope Announces Relaunch of Send2Press PR Partner Program

LOS ANGELES, CA – Aug. 10 (SEND2PRESS NEWSWIRE) — Send2Press(R), a leading targeted newswire service, announced today it will again offer its PR Partner Program to qualified ad agencies, PR pros, and marketing companies. The program, last offered in 2003, allows appropriate advertising firms to offer Send2Press news distribution and Internet marketing services and receive a partner discount, without having to meet volume requirements or pay a start-up fee.

Send2Press Newswire to Sponsor NARIP Music Marketing and PR Seminar

LOS ANGELES, CA – July 27 (SEND2PRESS NEWSWIRE) — Send2Press(R), a leading targeted newswire service, announced today it will sponsor a record industry workshop presented by the National Association of Record Industry Professionals (NARIP), entitled ‘Getting Ink & Working the ‘Net: Secrets, Tips & Tricks of Publicity & PR.’ The event instructor is Scott G ‘The G-Man,’ a successful recording artist and marketing guru, and will take place Tuesday, August 15th, 2006 at the Beverly Garland Theater in Studio City, California.

Secrets, Tips and Tricks of Publicity and PR to be Revealed in Seminar led by Scott G – The G-Man

LOS ANGELES, CA – July 14 (SEND2PRESS NEWSWIRE) — Building a brand in print and online often takes a public relations plan, but there are pathways to success that are not always visible to the public, says Scott G of G-Man Marketing. In a seminar called ‘Getting Ink & Working the ‘Net,’ which will be held on August 15 in Studio City, California, G will reveal some of the processes that get attention for a company, product, service, or recording artist.

Haute Coffee: Java Juice Coffee Extract Makes Perfect Brew for Organic and Kosher Consumers

VENICE, CA – July 6 (SEND2PRESS NEWSWIRE) — Java Juice(R) liquid coffee extract exemplifies green business practice, while honoring the higher authority of the laws of Kashruth. Contemporary cuisine meets Jewish Tradition in living-kosher.com/haute_coffee.htm.

Epeius Biotechnologies Initiates Tri-REX Vaccination Protocols for Breast Cancer

SAN MARINO, CA and MANILA, Philippines – July 5 (SEND2PRESS NEWSWIRE) — Epeius Biotechnologies today announced the opening of a Vaccine-assisted Phase I/II clinical trial for metastatic breast cancer that is refractory to conventional chemotherapy. The innovative protocol introduces Reximmune-C(TM), the second in a series of targeted biologic therapies designed to seek out, accumulate in, and destroy metastatic tumor nodules, while sparing normal cells and tissues.

VNR Service Relaunched by Send2Press Newswire

LOS ANGELES, CA – June 25 (SEND2PRESS NEWSWIRE) — Send2Press(R), a leading targeted newswire service, announced today the relaunch of its video news release, or VNR, production and distribution channel. As part of the revamped service offering, Send2Press will be both producing and disseminating client VNRs online and to the media for the first time since 2002. The service will allow any size company to showcase their news in a visual and dynamic Web-compatible presentation.

Epeius Biotechnologies Corporation Receives $400,000 Grant to Support Gene Therapy Trials for Pancreatic Cancer

SAN MARINO, CA – June 19 (SEND2PRESS NEWSWIRE) — Epeius Biotechnologies Corporation announced today that the Company has been awarded a $400,000 grant by the Lazarex Cancer Foundation to expand and support ongoing cancer gene therapy clinical trials for advanced and metastatic pancreatic cancer.

Nature Lovers Take Flight With Java Juice(R): Single Serving Organic Coffee Extract

VENICE, CA – June 2 (SEND2PRESS NEWSWIRE) — Problem: No time to brew whole-bean coffee. Solution: just add hot or cold water to a half-ounce packet of Java Juice for a cup of the freshest organic ‘on the go’ coffee available. On the trail, training for a race, or in the air, Java Juice, a 100% pure coffee extract has found its way from the Appalachian Trail to cycle shops, to farmers markets, to tackle boxes to culinary suppliers.

Reaching New Heights: Java Juice Liquid Coffee Extract Makes Huge Leap Forward in Backcountry Coffee

VENICE, CA – May 4 (SEND2PRESS NEWSWIRE) — No time for brewed specialty coffee? Need a quick, pick-me-up? No worries. On the trail, at home, or at the office, just add hot or cold water to Java Juice(R) for a cup of the freshest-coffee alternative available.

New Online Magazine for Advertising Industry Launched Today by Neotrope(R)

TORRANCE, CA – May 1 (SEND2PRESS NEWSWIRE) — Neotrope(R), an entertainment content and media company established in 1983, announced today the formal launch of Advertising Industry Newswire(TM), an online magazine with news, commentary, podcasts, articles and feature content covering the ad business from broadcast to Web.

Expanded Access Program for Rexin-G Provides Genetic Medicine to Cancer Patients, First Revenues for Epeius Biotechnologies

SAN MARINO, CA – Apr. 7 (SEND2PRESS NEWSWIRE) — Epeius Biotechnologies Corporation announced today that the Philippine Bureau of Food and Drugs (BFAD) has approved an Expanded Access Program for Rexin-G(TM), the lead product of Epeius Biotechnologies, developed for the treatment of metastatic cancer. Following the landmark approval of Rexin-G(TM) for the treatment of all solid tumors, the Expanded Access Program extends the clinical applications of the world’s first targeted genetic medicine to many more cancer patients and enables Epeius Biotechnologies to recoup some of the costs of its ongoing clinical trials in Manila.

Epeius Biotechnologies Establishes Corporate Headquarters in San Marino, California – Facilities Include a Clinical Research Unit Dedicated to Evaluating New Genetic Medicine for Cancer

SAN MARINO, CA – Apr. 4 (SEND2PRESS NEWSWIRE) — Epeius Biotechnologies Corporation announced today the establishment of its main corporate headquarters in San Marino, California. The specialty pharmaceutical company has been granted Orphan Drug Status by the FDA for its lead product Rexin-G(TM), an innovative anti-cancer agent that seeks out and destroys metastatic disease. Rexin-G(TM) has been tested in a wide variety of cancer types, including pancreatic cancer, breast cancer, colon cancer, uterine cancer, laryngeal cancer, smooth muscle cancer (leiomyosarcoma) and skin cancer (malignant melanoma).

New Album from The G-Man Released With Controversial Cover

LOS ANGELES, CA – Feb. 21 (SEND2PRESS NEWSWIRE) — Scott G, who records as The G-Man), has released his 5th full-length CD entitled MOTION POTION with a cover design that some church groups find suggestive and disturbing.

Neotrope Hosting Gives ‘The Boot’ to Texas – Recommends Companies Leave the Lone Star State Alone

TORRANCE, CA – Feb. 15 (SEND2PRESS NEWSWIRE) — Neotrope(R) Hosting today announced it will be moving all of its Web server hardware out of the co-location facilities located within the state of Texas, and specifically, Dallas County, due to an alleged ‘extortion tax’ on companies who co-locate computer equipment with hosting facilities in that state, after receiving a ‘property tax’ bill for 2005 which amounts to 8% of the value of the hardware simply for the pleasure of the machine sitting in a rack in Dallas County.

Neotrope Chosen to Provide Internet Marketing Solutions for Ask Ariel Your Pet Nutritionist located in Dana Point, CA

TORRANCE, CA – Jan. 6 (SEND2PRESS NEWSWIRE) — Neotrope(R), a leading California advertising, PR, and Internet Marketing firm established 1983, today announced it has been chosen by a holistic pet care and pet health supplement firm, Ask Ariel Your Pet Nutritionist (www.askariel.com), to provide promotion and brand development for their company and Website.

G-Man Music PSA for American Cancer Society Takes Listeners Inside the Human Body

LOS ANGELES, CA – Jan. 2 (SEND2PRESS NEWSWIRE) — Radio listeners become a cancer cell inside a human body as part of the new public service announcement created by G-Man Music & Radical Radio for the American Cancer Society.

TechGenii, Inc. Re-launches as an Interactive Strategy Company

LOS ANGELES, CA – Dec. 1 (SEND2PRESS NEWSWIRE) — TechGenii, Inc., an industry leader in mobile marketing and interactivity, today announced that it will re-launch its website to provide greater support for entertainment and media companies in their quest to build interactivity and mobilize content.

Neotrope Chosen as Agency of Record for SamuraiBaby.com

TORRANCE, Calif. – Nov. 7 (SEND2PRESS NEWSWIRE) — Neotrope(R), a leading advertising, PR, and Internet Marketing firm established 1983, today announced it has been chosen by SamuraiBaby.com, to act as the agency of record for the company’s PR and marketing efforts. As part of the agreement, Neotrope will help market the new book ‘Way of the Baby: A Book of Five Grins’ (ISBN: 0595358853) written by SamuraiBaby’s Brian Hutchins, and related ‘Samurai Baby’ customized art and gift items, and act as media liaison.

Marinello Schools of Beauty hosts their Second Annual International Beauty School Student Hair Competition

BEVERLY HILLS, Calif. (SEND2PRESS NEWSWIRE) — Marinello Schools of Beauty, the proven leader in beauty education and training since 1905, is proud to host the Takayama Schools of Beauty Team from Tokyo, Japan, for the ‘Second Annual International Beauty School Student Hair Competition.’ The event will be held on Saturday, October 1st at the recently renovated, state-of-the-art Marinello campus located in the Puente Hills Mall at 1600 Azusa Avenue, #244, City of Industry, Calif.

Clinical Trial For Pancreatic Cancer Opens at Mayo Clinic Using Tumor-Targeted Gene Therapy Vector

LOS ANGELES, Calif. – July 15 (SEND2PRESS NEWSWIRE) — Epeius Biotechnologies Corporation, announced today that a Phase I clinical trial has opened at Mayo Clinic Cancer Center, Rochester, Minnesota to test the safety of Rexin-G(TM), the first tumor-targeted gene therapy vector to gain Orphan Drug designation from the U.S. Food and Drug Administration (FDA) for the treatment of pancreatic cancer. The clinical protocol has passed the rigorous reviews of the FDA, the NIH/Recombinant Advisory Committee, and the Institutional Review Board of Mayo Clinic.

Marinello Schools of Beauty Celebrates its 100-Year Anniversary and the Grand Opening of a New Expanded Facility in City of Industry, CA

BEVERLY HILLS, Calif. (SEND2PRESS NEWSWIRE) — Marinello Schools of Beauty, the leader in cosmetology education and training since 1905, announces the grand opening of its expanded educational facility, located in the Puente Hills Mall at 1600 Azusa Avenue, Suite 244, in the City of Industry, Calif. The Grand Opening celebration will take place on Thursday, June 16th, 2005, beginning at 1:00 pm.

Rexin-G, the World’s First Tumor-Targeted Gene Delivery Vector Used in Phase I Clinical Trial

LOS ANGELES, Calif. — (SEND2PRESS NEWSWIRE) — Epeius Biotechnologies Corp. announced today that a Phase I clinical trial has opened in New York to test the safety and efficacy of Rexin-G, the leading tumor-targeted gene delivery system (vector) developed for the treatment of metastatic colon and pancreatic cancer.

Phase I Clinical Trial for Advanced Colon and Pancreatic Cancer Opens in New York Using Rexin-G, the World’s First Tumor-Targeted Gene Delivery Vector

LOS ANGELES, Calif. — (SEND2PRESS NEWSWIRE) — Epeius Biotechnologies Corporation (www.epeiusbiotech.com) announced today that a Phase I clinical trial has opened in New York to test the safety and efficacy of Rexin-G, the leading tumor-targeted gene delivery system (vector) developed for the treatment of metastatic colon and pancreatic cancer. In 2003, Rexin-G gained FDA approval as an Orphan Drug based on clinical demonstrations of the medical utility of Rexin-G as an effective treatment for pancreatic cancer.

Non-Profit Organizations to Receive $22K in Free PR Grants and Marketing Support

LOS ANGELES, Calif. /Send2Press Newswire/ — Neotrope(R), a brand identity and marketing firm established Jan. 1983, is donating $22K in free public relations and newswire services to worthy non-profit and charitable organizations to celebrate its 22nd anniversary. Neotrope previously donated $25K worth of services in 2000, and has provided discounted or free services to various non-profits for more than 20 years. Organizations may apply for this program starting Jan 28.